Anondita Medicare Limited Reports Strong Financial Performance with 108% PAT Growth in FY26
Mumbai, May 25, 2026: Anondita Medicare Limited, a prominent manufacturer of condoms and sexual wellness products operating under its flagship brand 'COBRA,' has reported robust financial performance for the fiscal year (FY) 2026 and the first half of FY26 (H2 FY26).The company announced that in FY26, its Revenue from Operations, EBITDA, and Net Profit grew significantly by 78%, 100%, and 108% year over year (YoY), respectively. The strong operational momentum continued into H2 FY26, where revenue grew 83% YoY, and Net Profit surged 103% YoY, demonstrating material margin expansion.
Financial Highlights Overview (Consolidated)
The financial results highlight sustained growth across core metrics. The company's annual and half-yearly performance metrics are summarized below:Annual Financial Highlights - FY26
| Metric | FY26 | FY25 |
|---|---|---|
| Revenue From Operation | (Data Not Available) | (Data Not Available) |
| EBITDA | (Data Not Available) | (Data Not Available) |
| Net Profit | (Data Not Available) | (Data Not Available) |
Half-Yearly Financial Highlights (YoY)
| Particular (In ₹Lakhs & Margin in %) | H2FY26 | H2FY25 | YoYChange |
|---|---|---|---|
| Revenue From Operation | 8,331.87 | 4,558.57 | 83% |
| EBITDA | 3,189.92 | 1,596.35 | 100% |
| EBITDA Margin (%) | 38.29% | 35.02% | 327 BPS |
| Net Profit | 2,127.86 | 1,047.47 | 103% |
| Net Profit Margin (%) | 25.54% | 22.98% | 256 BPS |
Management Commentary
Mr. Anupam Ghosh, Managing Director of Anondita Medicare Limited, commented on the results, stating, "We are pleased to report a strong performance for FY26 with Revenue, EBITDA, and Net Profit growing by 78%, 100%, and 108% respectively. The strong momentum continued, reflecting our focus on operational efficiency, capacity enhancement, and market penetration. In H2 FY26 the PAT margin grew by 103% YOY."He added that the company remains confident about sustaining long term growth momentum, citing the growing domestic demand, expanding international presence, and continued focus on innovative products.
About Anondita Medicare Limited
Anondita Medicare Limited is an Indian manufacturer specializing in condoms and sexual wellness products, operating its flagship brand 'COBRA.' The company maintains its own manufacturing facility, adhering to a quality-driven and compliant production model.Led by Mr. Anupam Ghosh, who possesses over 25 years of experience in the healthcare and contraceptive products industry, the organization benefits from deep industry expertise and entrepreneurial vision. With a strong domestic presence, particularly in North India, Anondita Medicare is focused on expanding across India and international markets. The company's strategy emphasizes automation led capacity enhancement and innovative patented female condom products to position it for scalable growth and long-term value creation.
ANONDITA Stock Price Movement
As of 12:58 PM, shares of Anondita Medicare Limited are shedding 4.62% in live trading, currently at ₹1052.05. The stock is seeing active liquidity, with 37,400 shares changing hands as the market continues its session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.